Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-21 Sale |
2025-01-23 4:19 pm |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
19,109 | $6.5877 | $125,884 | 364,305 (Indirect Direct) |
View |
| 2024-11-11 Sale |
2024-11-13 6:45 pm |
Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director |
8,687 | $10.85 | $94,238 | 10,139 (Direct) |
View |
| 2024-07-15 Sale |
2024-07-17 2:50 pm |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
33,848 | $11.72 | $396,699 | 381,574 (Indirect Direct) |
View |
| 2024-03-22 Sale |
2024-03-26 4:05 pm |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
16,851 | $9.11 | $153,513 | 414,624 (Indirect Direct) |
View |
| 2023-04-06 Purchase |
2023-04-07 3:19 pm |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
12,919 | $7.8199 | $101,025 | 190,526 (Indirect Direct) |
View |
| 2023-03-10 Sale |
2023-03-10 09:27 am |
Myovant Sciences Ltd. | MYOV | Curran Terrie Director |
3,673 | $0 | $0 | 0 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-03 6:59 pm |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
1,436 | $8.5411 | $12,265 | 177,607 (Indirect Direct) |
View |
| 2023-01-20 Sale |
2023-01-20 7:39 pm |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
5,821 | $8.1995 | $47,729 | 341,543 (Indirect Direct) |
View |
| 2022-11-21 Sale |
2022-11-23 4:07 pm |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
1,526 | $9.6 | $14,650 | 85,956 (Indirect Direct) |
View |
| 2022-05-13 Purchase |
2022-05-16 8:45 pm |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
20,500 | $7.4066 | $151,835 | 65,319 (Indirect Direct) |
View |
| 2021-09-09 Sale |
2021-09-13 4:11 pm |
Myovant Sciences Ltd. | MYOV | Curran Terrie Director |
4,850 | $25.58 | $124,063 | 5,250 (Direct) |
View |
| 2021-09-01 Sale |
2021-09-03 4:25 pm |
Myovant Sciences Ltd. | MYOV | Curran Terrie Director |
48,508 | $25.02 | $1,213,814 | 57,335 (Direct) |
View |
| 2021-03-22 Sale |
2021-03-23 7:22 pm |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
11,513 | $43.32 | $498,751 | 855,687 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-27 Option Award |
2025-03-03 5:16 pm |
N/A 2035-02-26 |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
342,500 | $0 | 342,500 (Direct) |
View |
| 2024-06-14 Option Award |
2024-06-18 4:52 pm |
N/A 2034-06-14 |
Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director |
37,191 | $0 | 45,878 (Direct) |
View |
| 2024-01-18 Option Award |
2024-01-22 8:19 pm |
N/A 2034-01-17 |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
475,000 | $0 | 475,000 (Direct) |
View |
| 2023-11-01 Option Award |
2023-11-03 4:53 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
37,500 | $0 | 430,751 (Direct) |
View |
| 2023-07-14 Option Award |
2023-07-17 5:00 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
200,000 | $0 | 393,251 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 7:10 pm |
N/A 2033-05-31 |
Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director |
16,595 | $0 | 20,907 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-20 7:39 pm |
N/A 2033-01-18 |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
260,000 | $0 | 341,543 (Direct) |
View |
| 2022-10-26 Option Award |
2022-10-28 4:45 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | Curran Terrie Director |
9,859 | $0 | 9,859 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-02 4:05 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
7,500 | $0 | 87,482 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:58 pm |
N/A 2032-06-01 |
Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director |
16,108 | $0 | 16,108 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 5:14 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
12,000 | $0 | 77,319 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 6:47 pm |
N/A 2032-01-18 |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
247,500 | $0 | 250,809 (Direct) |
View |
| 2021-11-05 Option Award |
2021-11-09 5:40 pm |
N/A 2031-11-04 |
Myovant Sciences Ltd. | MYOV | Curran Terrie Director |
21,096 | $0 | 21,096 (Direct) |
View |
| 2021-09-09 Exercise |
2021-09-13 4:11 pm |
N/A 2029-08-23 |
Myovant Sciences Ltd. | MYOV | Curran Terrie Director |
4,850 | $0 | 5,250 (Direct) |
View |
| 2021-09-09 Exercise |
2021-09-13 4:11 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | Curran Terrie Director |
4,850 | $7.65 | 5,250 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-03 4:25 pm |
N/A 2029-08-23 |
Myovant Sciences Ltd. | MYOV | Curran Terrie Director |
48,508 | $0 | 57,335 (Direct) |
View |
| 2021-09-01 Exercise |
2021-09-03 4:25 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | Curran Terrie Director |
48,508 | $7.65 | 57,335 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 4:36 pm |
N/A 2031-06-09 |
Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director |
13,391 | $0 | 13,391 (Direct) |
View |
| 2021-03-22 Exercise |
2021-03-23 7:22 pm |
N/A 2029-08-28 |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
11,513 | $0 | 855,687 (Direct) |
View |
| 2021-03-22 Exercise |
2021-03-23 7:22 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
11,513 | $6.95 | 855,687 (Direct) |
View |
| 2021-01-28 Option Award |
2021-01-29 4:27 pm |
N/A 2031-01-27 |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
225,000 | $0 | 225,000 (Direct) |
View |
| 2020-11-02 Option Award |
2020-11-04 4:34 pm |
N/A 2030-11-02 |
Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director |
37,500 | $0 | 37,500 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 4:16 pm |
N/A 2030-09-14 |
Myovant Sciences Ltd. | MYOV | Curran Terrie Director |
21,603 | $0 | 21,603 (Direct) |
View |
| 2020-07-01 Option Award |
2020-07-02 4:44 pm |
N/A 2030-06-30 |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
175,000 | $0 | 175,000 (Direct) |
View |